Navigation Links
Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis
Date:11/23/2009

se, pivotal, phase 3 clinical trial in cystinosis patients. Upon receiving FDA and EMEA concurrence, Raptor intends to initiate its phase 3 clinical trial at multiple sites in the US and Europe in the first quarter of 2010.

DR Cysteamine is Raptor's proprietary, enteric-coated micro-bead formulation of immediate release cysteamine bitartrate capsules, the current standard of care for treating cystinosis.

Bruce Barshop, M.D., Ph.D., Professor of Clinical Pediatrics at UCSD and principal investigator for the cystinosis clinical trial of DR Cysteamine, stated, "The excellent tolerability of DR Cysteamine, as demonstrated in this study, represents a major step forward in potentially improving the treatment of cystinosis. Raptor's formulation has the potential to improve dosing compliance and long-term outcomes for cystinosis patients."

Raptor's phase 2b clinical trial followed earlier clinical trials with an enteric-coated cysteamine prototype conducted by Ranjan Dohil, M.D., Associate Professor of Pediatrics at UCSD and funded by the Cystinosis Research Foundation ("CRF"). The CRF also supported Raptor's phase 2b clinical trial.

Patrice P. Rioux, M.D., Ph.D., chief medical officer of Raptor, said, "The results from our phase 2b trial are consistent with previous clinical findings from Dr. Dohil and support our plans to provide a twice-daily cysteamine therapy for cystinosis patients. We look forward to continuing our development program of DR Cysteamine in cystinosis with a phase 3 clinical trial."

Cystinosis is an inborn metabolic error characterized by the abnormal transport of cystine, an amino acid, out of the lysosomes. Failure to treat cystinosis can cause serious health consequences, including renal failure and resultant kidney transplant, growth failure, rickets, photophobia and blindness. Symptom onset typically occurs within the first year of life, when cystine crystals accumulate in various tissues and
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
2. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
3. Raptor Pharmaceutical Expands Board of Directors
4. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
5. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
6. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
7. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
8. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
9. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
10. Raptor Pharmaceuticals Provides Update on Targeting Platforms
11. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  Unilife Corporation ("Unilife" ... announced today that it intends to release its financial ... ended June 30, 2014 after market trading ends on ... scheduled a conference call for 4:30 p.m. U.S. EDT ... at 6:30 a.m. AEST), to review the Company,s financial results, ...
(Date:8/29/2014)... Research and Markets has announced ... Market 2014-2018" report to their offering. ... that results in demyelination, axonal transection, and neurodegeneration. The ... by the immune system, which targets neurons within the ... disease in which the damage of the myelin sheath ...
(Date:8/29/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... consumables to the medical, research and veterinary markets, announced ... Executive Officer, will present at the CL King 12 ... September 9, 2014 at 12:30 p.m. ET. The conference ... in New York City . ...
Breaking Medicine Technology:Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... 24 Sunridge International (OTC Bulletin Board: SNDZ ... month to have meetings with key brokers and funds.  The ... our company,s technology, and to facilitate funding for Sunridge to ... is a good time for this project," states G. Richard ...
... Corporation (Nasdaq: CLSN ), a leading ... U.S. Food and Drug Administration (FDA) has designated ... in combination with radiofrequency ablation (RFA), as a ... liposomal encapsulation of doxorubicin, is currently being evaluated ...
Cached Medicine Technology:Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer 2Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer 3Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer 4
(Date:8/29/2014)... USA (PRWEB) August 29, 2014 As reported ... Is Help (8/15), the process of admitting that you ... a struggle. The article acknowledges and highlights the fact that ... problem, you may be very overwhelmed by all of the ... is nearly impossible to sift through, it is still possible ...
(Date:8/29/2014)... Market Research Report on Global and ... and in-depth market survey on Global and Chinese ... basic information of Glass microfiber including its classification, ... global and China’s top manufacturers of Glass microfiber ... market share etc. , The report further analyzes ...
(Date:8/29/2014)... A recent article discusses the creation ... clothing store for men with gynecomastia, or male breasts, to ... their problem. Board-certified plastic surgeon Dr. Chasan is familiar with ... people only associate male breasts with men who are excessively ... of all ages, often starting in adolescence. Men with the ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 Pursuing ... is set to unveil a stunning new design ... to company figures, the highly notable surrogacy platform has ... January. With over 13,000 visitors a month, the FindSurrogateMother.com ... mothers working toward one common goal — the precious ...
(Date:8/29/2014)... report released yesterday by the Mental Health Commission ... health training and education that police personnel receive. ... issue for Canada,s police community, and today,s report ... enforcement and people with mental illnesses," says Queen,s ... an interest in the area of police psychology. ...
Breaking Medicine News(10 mins):Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Report advocates improved police training 2
... ... Michael Steele join Tea Party Support ( http://teapartysupport.com ) and the ... do whatever is necessary, including the use of any parliamentary device ... its tracks. ,Rush Limbaugh questioned Senate Minority Leader McConnell’s strategy ...
... , SAN DIEGO, Dec. 11 ... of post-secondary education services focused on providing higher access to ... graduate school specializing in psychology programs at the master,s and ... in Career Management and Counseling. , This specialization responds ...
... NEW YORK, Dec. 11 WebMD Health Corp. (Nasdaq: ... offer to purchase up to 5,700,000 shares of its common ... at 5:00 p.m., New York City time on December 10, ... Transfer & Trust Company, the Depositary for the tender offer, ...
... December 11 2009 (Portland, Ore.) More than 10 ... at risk for developing diabetes during pregnancy, according to a ... in the December issue of the Ethnicity and Disease ... women,s gestational diabetes risk is one-third higher than averageand more ...
... , ... Board legally recovers the books and records of U.S. Shanghai Chemical Corporation from Chinese Principals! ... (PRWEB) December 11, 2009 ... Axxexs Capital, Inc. was acquired by a Chinese chemical company in a reverse merger. Principals ...
... ... ... do not believe that they know much about depression , but are highly aware of ... National Alliance on Mental Illness (NAMI)., , ,See full survey results at http://www.nami.org/depression , ...
Cached Medicine News:Health News:Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible 2Health News:Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible 3Health News:Bridgepoint Education's University of the Rockies Introduces New Master of Arts Specialization in Career Management and Counseling 2Health News:WebMD Health Corp. Announces Preliminary Results of Its Tender Offer 2Health News:WebMD Health Corp. Announces Preliminary Results of Its Tender Offer 3Health News:Chinese-American and Korean-American women at highest risk for diabetes in pregnancy 2Health News:Chinese-American and Korean-American women at highest risk for diabetes in pregnancy 3Health News:New Board Gains Control of U.S. Shanghai Chemical Corporation 2Health News:Depression Survey: Implications for Diverse Communities 2Health News:Depression Survey: Implications for Diverse Communities 3
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish....
Oval solid 16 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Cross action serrated handle with polished finish....
Oval solid 15 mm wide lower plate. Open upper plate with inside dimensions 11 mm x 8 mm. Serrated handle with locking thumb screw and polished finish....
Slender 4.5 mm long rounded platform. Serrated handle with polished finish....
Medicine Products: